These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 9163609
1. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status. Egle A, Villunger A, Marschitz I, Kos M, Hittmair A, Lukas P, Grünewald K, Greil R. Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609 [Abstract] [Full Text] [Related]
2. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery. Gaumann A, Tews DS, Mayer E, Dahm M, Petrow PK, Otto M, Kirkpatrick CJ, Kriegsmann J. Cancer; 2001 Sep 01; 92(5):1237-44. PubMed ID: 11571738 [Abstract] [Full Text] [Related]
9. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Zhou M, Gu L, Yeager AM, Findley HW. Leukemia; 1998 Nov 01; 12(11):1756-63. PubMed ID: 9823951 [Abstract] [Full Text] [Related]
11. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T. Int J Cancer; 2002 Apr 01; 98(4):498-504. PubMed ID: 11920608 [Abstract] [Full Text] [Related]
12. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. Spets H, Georgii-Hemming P, Siljason J, Nilsson K, Jernberg-Wiklund H. Blood; 1998 Oct 15; 92(8):2914-23. PubMed ID: 9763578 [Abstract] [Full Text] [Related]
13. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines. Ng AY, Bales W, Veltri RW. Anal Quant Cytol Histol; 2000 Feb 15; 22(1):45-54. PubMed ID: 10696460 [Abstract] [Full Text] [Related]
14. Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line. Kuribayashi N, Hata H, Yoshida M, Sonoki T, Nagasaki A, Kimura T, Harada N, Matsuzaki H. Acta Haematol; 1999 Feb 15; 101(3):113-8. PubMed ID: 10352328 [Abstract] [Full Text] [Related]
17. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. J Immunol; 1998 Jun 15; 160(12):5735-41. PubMed ID: 9637482 [Abstract] [Full Text] [Related]
19. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M. Br J Cancer; 1998 Jun 15; 77(3):404-11. PubMed ID: 9472635 [Abstract] [Full Text] [Related]
20. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4. Koizumi T, Wang J, Suzuki Y, Masuda K, Watanabe T. Mol Immunol; 1996 Nov 15; 33(16):1247-53. PubMed ID: 9129161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]